title: Rocuronium and sugammadex as a novel management strategy in a patient with plasmacholinesterase deficiency presenting for electroconvulsive therapy.
authors.forename: S
authors.initials: S
authors.lastname: Eissa
authors.forename: K S
authors.initials: KS
authors.lastname: Lim
mesh_terms: D000732:Androstanols / Q000009:adverse effects; D002802:Cholinesterases / Q000172:deficiency*; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D019148:Neuromuscular Blockade; D009467:Neuromuscular Depolarizing Agents / Q000037:antagonists & inhibitors; D000077123:Rocuronium; D000077122:Sugammadex; D047408:gamma-Cyclodextrins
chemical_list: D000732:Androstanols; D009467:Neuromuscular Depolarizing Agents; D047408:gamma-Cyclodextrins; D000077122:Sugammadex; D002802:Cholinesterases; D000077123:Rocuronium